Ludwig J - Search Results

1

Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience.

Shiels MT, Czaja AJ, Taswell HF, Gerin JL, Purcell RH, Ludwig J, Rakela J, Nelson CA. Shiels MT, et al. Among authors: ludwig j. Gastroenterology. 1985 Dec;89(6):1230-4. doi: 10.1016/0016-5085(85)90637-7. Gastroenterology. 1985. PMID: 4054516

2

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis.

Czaja AJ, Rakela J, Ludwig J. Czaja AJ, et al. Among authors: ludwig j. Gastroenterology. 1988 Aug;95(2):448-53. doi: 10.1016/0016-5085(88)90503-3. Gastroenterology. 1988. PMID: 3391372

3

Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.

Wood JR, Czaja AJ, Taswell HF, Ludwig J, Rakela J, Chase R. Wood JR, et al. Among authors: ludwig j. Gastroenterology. 1987 Dec;93(6):1225-30. doi: 10.1016/0016-5085(87)90248-4. Gastroenterology. 1987. PMID: 3678739

4

Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.

Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF. Czaja AJ, et al. Among authors: ludwig j. Gastroenterology. 1983 Sep;85(3):713-7. Gastroenterology. 1983. PMID: 6192038

5

Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.

Davis GL, Czaja AJ, Ludwig J. Davis GL, et al. Among authors: ludwig j. Gastroenterology. 1984 Dec;87(6):1222-7. Gastroenterology. 1984. PMID: 6489694 Clinical Trial.

6

Frequency and significance of immunoglobulin M antibody to hepatitis B core antigen in corticosteroid-treated severe chronic active hepatitis B.

Czaja AJ, Shiels MT, Taswell HF, Wood JR, Ludwig J, Chase RC. Czaja AJ, et al. Among authors: ludwig j. Mayo Clin Proc. 1988 Feb;63(2):119-25. doi: 10.1016/s0025-6196(12)64944-1. Mayo Clin Proc. 1988. PMID: 3339905

7

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis.

Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Kenny RP, et al. Among authors: ludwig j. Dig Dis Sci. 1986 Jul;31(7):705-11. doi: 10.1007/BF01296447. Dig Dis Sci. 1986. PMID: 3720467

8

Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.

Davis GL, Czaja AJ, Taswell HF, Ludwig J, Go VL. Davis GL, et al. Among authors: ludwig j. Dig Dis Sci. 1985 Feb;30(2):97-103. doi: 10.1007/BF01308192. Dig Dis Sci. 1985. PMID: 3967568

9

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis.

Czaja AJ, Davis GL, Ludwig J, Taswell HF. Czaja AJ, et al. Among authors: ludwig j. Hepatology. 1984 Jul-Aug;4(4):622-7. doi: 10.1002/hep.1840040409. Hepatology. 1984. PMID: 6745850 Clinical Trial.

10

Hepatitis C antibodies in patients with chronic hepatitis of unknown etiology after orthotopic liver transplantation.

Poterucha JJ, Rakela J, Ludwig J, Taswell HF, Wiesner RH. Poterucha JJ, et al. Among authors: ludwig j. Transplant Proc. 1991 Feb;23(1 Pt 2):1495-7. Transplant Proc. 1991. PMID: 1846469 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

976 results

Search Page

Filters